Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
62.9M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
58.4M
-
Shares change
-
+1.78M
-
Total reported value, excl. options
-
$419M
-
Value change
-
+$13.1M
-
Put/Call ratio
-
3.79
-
Number of buys
-
68
-
Number of sells
-
-58
-
Price
-
$7.17
Significant Holders of MACROGENICS INC - COM (MGNX) as of Q1 2023
155 filings reported holding MGNX - MACROGENICS INC - COM as of Q1 2023.
MACROGENICS INC - COM (MGNX) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.4M shares
of 62.9M outstanding shares and own 92.9% of the company stock.
Largest 10 shareholders include Bellevue Group AG (9.61M shares), BlackRock Inc. (6M shares), ARMISTICE CAPITAL, LLC (5.96M shares), VANGUARD GROUP INC (4.47M shares), T. Rowe Price Investment Management, Inc. (2.91M shares), MILLENNIUM MANAGEMENT LLC (1.95M shares), Frazier Life Sciences Management, L.P. (1.7M shares), Assenagon Asset Management S.A. (1.49M shares), SILVERARC CAPITAL MANAGEMENT, LLC (1.36M shares), and WASATCH ADVISORS LP (1.32M shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.